Chlormadinone acetate
Chlormadinone acetate is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Searched
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
G: Genito urinary system and sex hormones
— G03: Sex hormones and modulators of the genital system
— G03A: Hormonal contraceptives for systemic use
— G03AA: Progestogens and estrogen systemic contraceptives, fixed combinations
— G03AA15: Chlormadinone and ethinylestradiol
— G03AB: Progestogens and estrogens systemic contraceptives, sequential preparations
— G03AB07: Chlormadinone and ethinylestradiol
— G03D: Progestogen sex hormones and modulators of the genital system
— G03DB: Pregnadien derivatives, progestogens
— G03DB06: Chlormadinone
— G03F: Progestogens and estrogens in combination
— G03FB: Progestogens and estrogens, sequential preparations
— G03FB03: Chlormadinone and estrogen
HCPCS
No data
Clinical
Clinical Trials
112 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Contraception | D003267 | 5 | 3 | — | 8 | 7 | 21 | ||
| Endometrial neoplasms | D016889 | EFO_0004230 | — | 8 | 2 | 1 | — | 10 | |
| Hiv infections | D015658 | EFO_0000764 | B20 | 1 | 3 | — | 1 | 3 | 8 |
| Postmenopause | D017698 | 1 | 1 | 3 | 1 | — | 6 | ||
| Endometrial hyperplasia | D004714 | N85.0 | — | 2 | 1 | 2 | — | 5 | |
| Hot flashes | D019584 | — | 2 | 2 | 1 | — | 5 | ||
| Hiv | D006678 | O98.7 | — | 1 | — | 3 | 1 | 5 | |
| Osteoporosis | D010024 | EFO_0003882 | M81.0 | — | — | 3 | 1 | — | 4 |
| Metrorrhagia | D008796 | HP_0100608 | N92.1 | — | — | 1 | 2 | 1 | 4 |
| Infertility | D007246 | EFO_0000545 | — | — | 1 | 2 | — | 3 |
Show 7 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | 1 | 4 | — | 1 | 5 |
| Coronary disease | D003327 | — | 1 | 5 | — | — | 5 | ||
| Heart diseases | D006331 | EFO_0003777 | I51.9 | — | 1 | 5 | — | — | 5 |
| Menopause | D008593 | EFO_0003922 | N95 | — | 1 | 2 | — | — | 3 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 1 | 2 | — | — | 3 |
| Healthy volunteers/patients | — | 2 | 1 | 1 | — | — | 3 | ||
| Menorrhagia | D008595 | N92.0 | — | — | 2 | — | 1 | 3 | |
| Uterine hemorrhage | D014592 | — | — | 1 | — | 2 | 3 | ||
| Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | — | 3 | — | — | 3 |
| Hypertension | D006973 | EFO_0000537 | I10 | — | 1 | 1 | — | — | 2 |
Show 13 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Endometrioid carcinoma | D018269 | — | 2 | — | — | — | 2 | ||
| Tuberculosis | D014376 | EFO_0000774 | A15-A19 | — | 1 | — | — | — | 1 |
| Prehypertension | D058246 | — | 1 | — | — | — | 1 | ||
| Primary ovarian insufficiency | D016649 | EFO_0004266 | E28.3 | — | 1 | — | — | — | 1 |
| Persistent fetal circulation syndrome | D010547 | EFO_1001103 | P29.3 | — | 1 | — | — | — | 1 |
| Myelodysplastic syndromes | D009190 | D46 | — | 1 | — | — | — | 1 |
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Postcoital contraception | D044363 | 1 | — | — | — | 1 | 2 | ||
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Vitamin d deficiency | D014808 | EFO_0003762 | E55 | — | — | — | — | 1 | 1 |
| Polycystic ovary syndrome | D011085 | EFO_0000660 | E28.2 | — | — | — | — | 1 | 1 |
| Cognitive dysfunction | D060825 | G31.84 | — | — | — | — | 1 | 1 | |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.81 | — | — | — | — | 1 | 1 |
| Contraception behavior | D003268 | — | — | — | — | 1 | 1 | ||
| Hormonal contraception | D000080282 | — | — | — | — | 1 | 1 | ||
| Breast feeding | D001942 | — | — | — | — | 1 | 1 | ||
| Chlamydia infections | D002690 | EFO_0007205 | A74.9 | — | — | — | — | 1 | 1 |
| Neisseriaceae infections | D016870 | EFO_1001377 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | CHLORMADINONE ACETATE |
| INN | chlormadinone |
| Description | Chlormadinone acetate is a corticosteroid hormone. |
| Classification | Small molecule |
| Drug class | Progestogen; Progestin; Progestogen ester; Antigonadotropin; Steroidal antiandrogen |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C |
Identifiers
| PDB | — |
| CAS-ID | 302-22-7 |
| RxCUI | 2369 |
| ChEMBL ID | CHEMBL110691 |
| ChEBI ID | 31394 |
| PubChem CID | 9324 |
| DrugBank | DB15903 |
| UNII ID | SDS4N642GG (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 562 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more